Regenerative technologies to bed side: Evolving the regulatory framework

There are high expectations for the clinical application of regenerative medicine technologies to treat musculoskeletal disorders. However, there are still big hurdles in bringing cell-based products to the market, mainly due to strict regulatory frameworks to approve these. Recently, the Japanese P...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Orthop Translat
Prif Awduron: Sakai, Daisuke, Schol, Jordy, Foldager, Casper B., Sato, Masato, Watanabe, Masahiko
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Chinese Speaking Orthopaedic Society 2017
Pynciau:
Review Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5822969/
https://ncbi.nlm.nih.gov/pubmed/29662794
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jot.2017.02.001
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg